These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33036240)

  • 1. Drug Delivery Systems of Natural Products in Oncology.
    Colone M; Calcabrini A; Stringaro A
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33036240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers as Administration Systems of Natural Products.
    Solís-Cruz GY; Pérez-López LA; Alvarez-Roman R; Rivas-Galindo VM; Silva-Mares DA; Ibarra-Rivera TR
    Curr Top Med Chem; 2021; 21(26):2365-2373. PubMed ID: 34525921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural product-based nanomedicine: recent advances and issues.
    Watkins R; Wu L; Zhang C; Davis RM; Xu B
    Int J Nanomedicine; 2015; 10():6055-74. PubMed ID: 26451111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale Delivery Systems: Actual and Potential Applications in the Natural Products Industry.
    Simona AD; Florina A; Rodica CA; Evelyne O; Maria-Corina S
    Curr Pharm Des; 2017; 23(17):2414-2421. PubMed ID: 28228070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug Targeting.
    Azandaryani AH; Kashanian S; Jamshidnejad-Tosaramandani T
    Curr Pharm Biotechnol; 2019; 20(7):526-541. PubMed ID: 31038063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy.
    Bhusare N; Gade A; Kumar MS
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23732. PubMed ID: 38769657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant.
    Liang Y; Liu ZY; Wang PY; Li YJ; Wang RR; Xie SY
    J Control Release; 2021 Aug; 336():396-409. PubMed ID: 34175367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.
    Joanitti GA; Ganassin R; Rodrigues MC; Figueiro Longo JP; Jiang CS; Gu J; Leal Pinto SM; Almeida Dos Santos MF; de Azevedo RB; Muehlmann LA
    Mini Rev Med Chem; 2017; 17(3):224-236. PubMed ID: 27739361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents.
    Bhattacharya T; Maishu SP; Akter R; Rahman MH; Akhtar MF; Saleem A; Bin-Jumah M; Kamel M; Abdel-Latif MA; Abdel-Daim MM
    Curr Top Med Chem; 2021; 21(12):1014-1026. PubMed ID: 33845744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.
    Krishnan V; Rajasekaran AK
    Clin Pharmacol Ther; 2014 Feb; 95(2):168-78. PubMed ID: 24013811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
    Shen S; Liu M; Li T; Lin S; Mo R
    Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine in cancer treatment.
    Yih TC; Wei C
    Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
    Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology to improve the Alzheimer's disease therapy with natural compounds.
    Ramalho MJ; Andrade S; Loureiro JA; do Carmo Pereira M
    Drug Deliv Transl Res; 2020 Apr; 10(2):380-402. PubMed ID: 31773421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine-Cum-Carrier by Co-Assembly of Natural Small Products for Synergistic Enhanced Antitumor with Tissues Protective Actions.
    Wang J; Zhao H; Qiao W; Cheng J; Han Y; Yang X
    ACS Appl Mater Interfaces; 2020 Sep; 12(38):42537-42550. PubMed ID: 32852938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.